CoChat

Polycystic Kidney Disease

Igarashi, Peter, Somlo, Stefan · 2007 · Journal of the American Society of Nephrology
Cited by 56

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Abstract

Polycystic kidney disease (PKD) is the most common genetic cause of kidney failure in adults and children. PKD is characterized by progressive cystic dilation of the renal tubules, which results in nephromegaly and often culminates in end-stage renal disease. PKD can be inherited as either an autosomal dominant trait (ADPKD) or autosomal recessive trait (ARPKD). Since our last review on this subject in 2002 (1), there have been tremendous advances in the understanding of the genetics and pathogenesis of PKD. The localization of the PKD proteins polycystin-1, polycystin-2, and fibrocystin in the primary cilium has renewed attention on this neglected organelle and rejuvenated an entire field of cell biology. The elucidation of the signaling pathways that are disrupted in cyst epithelial cells has provided new targets for therapeutic intervention. The generation of orthologous animal models, especially knockout mice, has enabled preclinical evaluation of drugs that target these pathways and accelerated their use in clinical studies of patients with PKD. Concomitant with the discoveries in basic science research, there have also been major advances on the clinical research front. The National Institute of Diabetes, Digestive, and Kidney Diseases (NIDDK) has sponsored several major clinical studies on PKD. One recently completed study, the Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) study, has provided new insights into disease progression and measurement. The purpose of this Frontiers miniseries is to review some recent basic and clinical research on PKD. Because of the broad ongoing investigations in this field, it is not possible to provide a comprehensive review. Rather, two articles will discuss basic research on molecular pathogenesis, focusing on the roles of primary cilia, Wnt signaling, and planar cell polarity. Two more articles will summarize clinical research on genotype–phenotype correlations, diagnosis, and emerging therapies. ADPKD is caused by mutations of PKD1 or PKD2, which produce similar clinical manifestations, although kidney failure and other clinical symptoms occur earlier in patients with mutations of PKD1. All cases of ARPKD appear to arise from mutations of PKHD1. Since the original cloning of the PKD genes, many different mutations have been identified in affected individuals. In the first article (2), Drs Rossetti and Harris at the Mayo Clinic review what has been learned about genotype-phenotype correlations in PKD. These investigators and their collaborators have compiled large databases of DNA samples from PKD patients and have attempted to correlate the mutations with various clinical features of the disease. The goal of this work is to find better prognostic indicators and to identify regions of the proteins that are critical for function. For example, Rosetti et al. found that mutations located toward the 5′ end of the PKD1 gene are associated with earlier onset of end-stage renal disease and increased risk of ruptured intracranial aneurysms (3). In the case of ARPKD, the presence of two truncating mutations in PKHD1 produces a severe and lethal neonatal form of the disease, whereas patients with at least one missense mutation may survive to adolescence or even adulthood when they present with hepatic fibrosis as the primary manifestation (4). The review by Rossetti and Harris emphasizes the great variability in the severity and manifestations of PKD even between individuals from the same family who carry identical germline mutations. Recent work has begun to identify the genetic modifier and environmental factors that may contribute to this heterogeneity. A major insight into the pathophysiology of PKD was revealed by the discovery that the proteins encoded by the PKD genes are located in primary cilia. In the second article (5), Dr Yoder at the University of Alabama at Birmingham reviews the structure and function of primary cilia. Primary cilia are solitary hair-like sensory organelles that project from the cell surface. Studies first performed in C. elegans showed that homologs of polycystin-1 and polycystin-2 are located in sensory cilia (6). This surprising finding was subsequently verified by Dr Yoder and others in kidney epithelial cells. In the kidney, primary cilia project into the tubule lumen and may have a mechanosensory function. The loss of polycystin-1 or polycystin-2 in cilia is believed to disrupt a calcium-dependent signaling pathway that leads to dysregulated cell proliferation and structure and/or increased fluid secretion. Similarly, Dr Yoder and others found that fibrocystin, the protein mutated in ARPKD, is also located in primary cilia, which raises the possibility of a common cystogenic mechanism in ADPKD and ARPKD. Moreover, several proteins involved in other diseases that manifest renal cysts, such as nephronophthisis and Bardet-Biedl syndrome, have also been found in the primary cilium and/or the basal body that an

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1681/asn.2007030299

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 20 references

Cited by

See all 56

Metadata

Authors
Igarashi, P., & Somlo, S.
Venue
Journal of the American Society of Nephrology
Published
2007-05
Volume
18
Issue
5
Pages
1371-1373
ISSN
1046-6673 (ISSN-L)
OpenAlex
W2015498271
Cited by
56
References
20
FWCI
1.67
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Polycystic Kidney Disease. https://app.cochat.ai/papers/10.1681/asn.2007030299
The paper
Igarashi, P., & Somlo, S. (2007). Polycystic Kidney Disease. Journal of the American Society of Nephrology. https://doi.org/10.1681/asn.2007030299

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.